Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|7|639-646

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.7, 2015-07, pp. : 639-646

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 213-221

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis

By  

Acta Haematologica, Vol. 138, Iss. 2, 2017-09 ,pp. : 116-118

Karger

Access to resources Recommend Favorite

High-Intensity Induction Chemotherapy Is Feasible for Elderly Patients with Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 55-64

Karger

Access to resources Recommend Favorite

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4162-4169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia

By  

Oncology Research and Treatment, Vol. 35, Iss. 6, 2012-05 ,pp. : 335-340

Karger

Access to resources Recommend Favorite